Filing Details
- Accession Number:
- 0001209191-14-065256
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-29 16:36:50
- Reporting Period:
- 2014-10-27
- Filing Date:
- 2014-10-29
- Accepted Time:
- 2014-10-29 16:36:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Corp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-27 | 1,125 | $48.74 | 18,125 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-27 | 119 | $108.54 | 18,006 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-27 | 490 | $109.43 | 17,516 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-27 | 229 | $110.60 | 17,287 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-27 | 287 | $111.21 | 17,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-27 | 1,125 | $0.00 | 1,125 | $48.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,875 | 2022-07-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $108.54 (range $107.93 to $108.83).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $109.43 (range $108.96 to $109.93).
- Open market sales reported on this line occurred at a weighted average price of $110.60 (range $110.00 to $110.95).
- Open market sales reported on this line occurred at a weighted average price of $111.21 (range $111.00 to $111.64).
- The option vests in 16 quarterly installments from 07/25/2012.
Billionaire Hedge Funds
